Victory Capital Management Inc. Has $6.47 Million Stock Position in DaVita Inc. (NYSE:DVA)

Victory Capital Management Inc. raised its position in shares of DaVita Inc. (NYSE:DVA) by 10.2% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 43,272 shares of the company’s stock after purchasing an additional 4,009 shares during the quarter. Victory Capital Management Inc. owned approximately 0.05% of DaVita worth $6,471,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the company. MML Investors Services LLC lifted its position in shares of DaVita by 1.3% during the 3rd quarter. MML Investors Services LLC now owns 5,300 shares of the company’s stock valued at $869,000 after acquiring an additional 68 shares during the period. Exchange Traded Concepts LLC raised its holdings in shares of DaVita by 8.3% during the fourth quarter. Exchange Traded Concepts LLC now owns 891 shares of the company’s stock valued at $133,000 after purchasing an additional 68 shares during the period. Impact Partnership Wealth LLC boosted its position in shares of DaVita by 3.7% during the 4th quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company’s stock worth $290,000 after purchasing an additional 70 shares in the last quarter. Contravisory Investment Management Inc. grew its stake in shares of DaVita by 1.2% in the 4th quarter. Contravisory Investment Management Inc. now owns 6,082 shares of the company’s stock valued at $910,000 after buying an additional 73 shares during the period. Finally, Nilsine Partners LLC grew its stake in shares of DaVita by 0.8% in the 4th quarter. Nilsine Partners LLC now owns 11,160 shares of the company’s stock valued at $1,669,000 after buying an additional 92 shares during the period. Institutional investors own 90.12% of the company’s stock.

Wall Street Analysts Forecast Growth

DVA has been the topic of several recent research reports. Cowen reiterated a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price target on DaVita in a report on Friday, February 21st. Finally, Barclays increased their price target on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 18th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $166.33.

DaVita Trading Up 1.7 %

NYSE DVA opened at $143.56 on Friday. DaVita Inc. has a 1-year low of $125.64 and a 1-year high of $179.60. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. The stock has a 50-day moving average of $158.92 and a 200-day moving average of $157.60. The firm has a market cap of $11.48 billion, a PE ratio of 13.37, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, sell-side analysts forecast that DaVita Inc. will post 10.76 EPS for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.